Vimab Group AB (publ) (STO:VIMAB)
Sweden · Delayed Price · Currency is SEK 3.260
-0.300 (-8.43%)
At close: Sep 25, 2026
Vimab Group AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 337.94 | 313.44 | 323.56 | 341.56 | 224.83 | 203.32 |
| 337.94 | 313.44 | 323.56 | 341.56 | 224.83 | 203.32 | |
Revenue Growth | 14.60% | -3.13% | -5.27% | 51.92% | 10.58% | -6.24% |
Cost of Revenue | 288.98 | 269.44 | 245.27 | 233.02 | 164.35 | 157.04 |
Gross Profit | 48.96 | 44 | 78.29 | 108.55 | 60.48 | 46.29 |
Selling, General & Admin | 80.86 | 80 | 97.4 | 83.56 | 57.41 | 56.02 |
Other Operating Expenses | 4.69 | 7.39 | -2.82 | -1.88 | -3.54 | -5.24 |
Operating Expenses | 125.67 | 129.35 | 157.78 | 106.86 | 74.65 | 67.64 |
Operating Income | -76.7 | -85.35 | -79.49 | 1.69 | -14.17 | -21.35 |
Interest Expense | -15.27 | -22.51 | -7.47 | -9.2 | -2.44 | -4.82 |
Interest & Investment Income | 0.04 | 0.04 | 0.12 | 3.98 | 0.08 | 3.9 |
Earnings From Equity Investments | - | - | - | -7.01 | - | - |
Currency Exchange Gain (Loss) | 0.29 | 0.29 | 1.82 | 1.93 | 0.46 | - |
Other Non Operating Income (Expenses) | -5.81 | -1.89 | -1.28 | 0.3 | - | - |
EBT Excluding Unusual Items | -97.46 | -109.43 | -86.29 | -8.31 | -16.07 | -22.27 |
Gain (Loss) on Sale of Investments | -0.01 | -0.01 | -0.03 | - | - | -2.49 |
Gain (Loss) on Sale of Assets | 1.39 | 1.39 | 0.74 | 3.06 | - | 0.12 |
Other Unusual Items | 10.92 | 5.87 | - | - | -15.75 | - |
Pretax Income | -85.16 | -102.18 | -85.58 | -5.25 | -31.82 | -24.64 |
Income Tax Expense | -0.51 | -0.5 | -0.76 | 1.16 | 2.4 | -0.56 |
Earnings From Continuing Operations | -84.65 | -101.68 | -84.82 | -6.41 | -34.22 | -24.09 |
Minority Interest in Earnings | - | - | 7.88 | 2.15 | - | - |
Net Income | -84.65 | -101.68 | -76.94 | -4.26 | -34.22 | -24.09 |
Net Income to Common | -84.65 | -101.68 | -76.94 | -4.26 | -34.22 | -24.09 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 36 | 26 | 23 | 21 | 10 | 3 |
Shares Outstanding (Diluted) | 36 | 26 | 23 | 21 | 10 | 3 |
Shares Change | 45.01% | 12.12% | 10.99% | 110.97% | 265.91% | - |
EPS (Basic) | -2.36 | -3.90 | -3.31 | -0.20 | -3.44 | -8.87 |
EPS (Diluted) | -2.36 | -3.90 | -3.31 | -0.20 | -3.44 | -8.87 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -39.46 | -22 | -0.58 | 6.4 | 1.21 | -8.58 |
Free Cash Flow Per Share | -1.10 | -0.84 | -0.03 | 0.30 | 0.12 | -3.16 |
Gross Margin | 14.49% | 14.04% | 24.20% | 31.78% | 26.90% | 22.77% |
Operating Margin | -22.70% | -27.23% | -24.57% | 0.49% | -6.30% | -10.50% |
Profit Margin | -25.05% | -32.44% | -23.78% | -1.25% | -15.22% | -11.85% |
Free Cash Flow Margin | -11.68% | -7.02% | -0.18% | 1.88% | 0.54% | -4.22% |
EBITDA | -48.92 | -55.73 | -16.31 | 26.86 | 5.62 | -3.17 |
EBITDA Margin | -14.47% | -17.78% | -5.04% | 7.87% | 2.50% | -1.56% |
D&A For EBITDA | 27.79 | 29.63 | 63.18 | 25.18 | 19.78 | 18.19 |
EBIT | -76.7 | -85.35 | -79.49 | 1.69 | -14.17 | -21.35 |
EBIT Margin | -22.70% | -27.23% | -24.57% | 0.49% | -6.30% | -10.50% |
Revenue as Reported | 351.85 | 328.64 | 330.25 | 347.82 | 229.25 | 209.04 |